https://www.selleckchem.com/pr....oducts/Odanacatib-(M
16 [95% CI 1.07-1.25] p .001). Outcomes for carotid stent capable IC performing EVT for AIS are comparable to those achieved by NI physicians in major randomized clinical trials. Our data supports conducting a clinical trial of carotid stent capable IC working on multidisciplinary stroke teams to perform EVT for AIS due to LVO in communities and hospitals without timely access (60 min by ground transport) to dedicated NI. Outcomes for carotid stent capable IC performing EVT for AIS are comparable to those achieved b
Aimer
Commentaire
Partagez
